Additionally, a nuclear transcription factor-κB (NF-κB) modulating the expression of genes involved in inflammation, immunity, proliferation, and apoptosis is constitutively activated in HNSCC, and affects the therapeutic resistance [19]. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.